The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 29.00
Low: 28.50
Prev. Close: 28.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Key Technology Development Milestone

20 Nov 2023 07:00

RNS Number : 8931T
Ilika plc
20 November 2023
 

Ilika plc

("Ilika" or the "Company")

 

Achievement of Key Technology Development Milestone

 

Ilika development team reaches design-freeze milestone for first customer prototype release of Goliath battery.

 

Ilika (AIM: IKA), a pioneer in solid state battery technology, announces it has achieved its D4 development point, which is a design-freeze milestone in the Goliath roadmap upon which Ilika's first prototype for customer release, P1, is based. The P1 prototype is an intermediate milestone on Ilika's roadmap to its minimum viable product (MVP) in 2025. The P1 Goliath prototype is a solid-state pouch cell with an NMC cathode and a silicon anode.

 

The D4 development point is an important milestone for the Company, effectively marking the start of Goliath's productization journey, being the essential marker for the P1 prototype. The D4 development point means that a number of key data sets - including energy density and power density have been met while showing that the Company is firmly on track to achieve lithium-ion energy parity by the end of the current calendar. Given the data sets that are now achievable the Company will be able to create P1 samples, which comprise four layer stacks, for sale to OEMs for testing.

 

Over the next six months, Ilika will manufacture and test batches of pouch cells based on the D4 development point prior to delivering fully characterized P1 cells to up to 15 customers in 2024. Ilika is currently in discussions with its customer base for Goliath batteries, which is primarily automotive OEMs, but also includes Tier 1 automotive suppliers and consumer appliance companies.

 

Work is continuing on Ilika's roadmap through to MVP, for which the corresponding D8 development point will be achieved at the end of 2024. The MVP, or P2 prototypes will be stackable to 30 layers, underpinning licensing opportunities. Further detail re the product curve and development points can be found on page 11 of the Company's 2023 Annual Report, which is available by clicking here.

 

Graeme Purdy, Ilika CEO, stated: "Achieving our D4 development point is an important milestone on our technology roadmap, as it forms the basis of our first prototype product pilot run, with the objective of sharing prototypes with our customer base in 2024. This achievement is a clear demonstration that the Ilika team is working very efficiently with the available resources to achieve credible outcomes for our customers within the ambitious timeframes that we have set."

 

 

 

For more information contact:

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR

Jason Stewart, Chief Financial Officer

Liberum Capital Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber,

Nikhil Varghese

Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Matthew Armitt, Mark Whitmore, Detlir Elezi,

Natasha Ninkov

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Nick Rome

Mob: 07748 325 236

 

About Ilika plc - https://www.ilika.com

Ilika specialises in the developing and commercialisation of solid state batteries. The Company's mission is to rapidly develop leading-edge IP, manufacture and license solid state batteries for markets that cannot be addressed with conventional batteries due to their safety, charge rates, energy density and life limits. The Company achieves this by using ceramic-based lithium-ion technology that is inherently safe in manufacture and usage, higher thermal tolerance and easier to recycle which differentiates our products from existing batteries.

 

The Company has two product lines. Its Stereax batteries which are designed for powering miniature medical implants, industrial wireless sensors and specialist internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDDLFFXFLXFBB
Date   Source Headline
23rd Apr 20122:44 pmRNSHolding(s) in Company
23rd Apr 20128:01 amRNSDirector/PDMR Shareholding
20th Apr 201212:49 pmRNSGeneral Meeting Results
4th Apr 201212:26 pmRNSPosting of circular
4th Apr 20127:00 amRNSPlacing and Subscription
13th Mar 20127:00 amRNSContract Renewals and Trading Update
2nd Feb 20127:00 amRNSJoint Development agreement with Energizer
10th Jan 20127:00 amRNSHalf Yearly Report
9th Jan 20127:00 amRNSNew contract with Toshiba
6th Dec 20117:00 amRNSAltrika grant award and new JDP
28th Nov 20117:00 amRNSSolid State Battery Development
16th Nov 20117:00 amRNSTrading Update
29th Sep 20118:21 amRNSFirst US electronics contract / Expansion in Asia
13th Sep 20115:06 pmRNSResult of AGM
2nd Aug 20117:00 amRNSPosting of annual report
14th Jul 20117:00 amRNSFull Year Results
4th May 20117:00 amRNSTrading Update
18th Apr 20117:00 amRNSCarbon Trust Grant / New Customer Contract
4th Mar 20118:00 amRNSRenewal of Contracts
24th Feb 20112:56 pmRNSNotification of Interest
23rd Feb 201112:16 pmRNSNotification of Interest
19th Jan 20113:00 pmRNSDISTRIBUTION OF INTERIM ACCOUNTS FOR 2010
24th Nov 20107:00 amRNSInterim Results
29th Oct 20107:00 amRNSIlika awarded Carbon Trust R&D Grant
21st Oct 20107:00 amRNSAgreement with Ministry of Defence agency
21st Oct 20107:00 amRNSAgreement with Ministry of Defence agency
20th Oct 20104:35 pmRNSAnnual Financial Report
20th Oct 20104:35 pmRNSAnnual Financial Report
8th Oct 201010:30 amRNSInternational Business Development Appointments
8th Sep 20107:00 amRNSRevenue Update and Contract Renewal
18th Aug 20104:13 pmRNSNotification of Interest
17th Aug 20107:00 amRNSTotal Voting Rights
5th Aug 20104:05 pmRNSHolding(s) in Company
28th Jul 20107:00 amRNSUK Government Grant for Skin Wound Treatment
15th Jul 20107:00 amRNSFuel Cell Materials Joint Development Project
15th Jul 20107:00 amRNSFinal Results
30th Jun 20107:00 amRNSDevelopment Project
16th Jun 20107:00 amRNSFuel cell catalyst scale-up agreement
10th Jun 201012:39 pmRNSInspection, Regulatory Authority for Skin Products
9th Jun 20109:25 amRNSIlika partners to develop business in China
2nd Jun 20104:25 pmRNSExercise of Options
14th May 20105:16 pmRNSGrant of Options
14th May 20105:16 pmRNSGrant of Options
14th May 20108:02 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.